Free Trial
NASDAQ:AQB

AquaBounty Technologies 4/1/2024 Earnings Report

AquaBounty Technologies logo
$0.80 +0.02 (+2.48%)
Closing price 04:00 PM Eastern
Extended Trading
$0.78 -0.02 (-2.55%)
As of 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AquaBounty Technologies EPS Results

Actual EPS
-$2.19
Consensus EPS
-$1.52
Beat/Miss
Missed by -$0.67
One Year Ago EPS
N/A

AquaBounty Technologies Revenue Results

Actual Revenue
$0.55 million
Expected Revenue
$0.73 million
Beat/Miss
Missed by -$180.00 thousand
YoY Revenue Growth
N/A

AquaBounty Technologies Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

AquaBounty Technologies' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Conference Call Resources

AquaBounty Technologies Earnings Headlines

AQB AquaBounty Technologies, Inc. - Seeking Alpha
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
AquaBounty Sinks on ’24 Figures
AquaBounty warned by Nasdaq over share price
AquaBounty Technologies Faces Leadership Change and Operational Halt
See More AquaBounty Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AquaBounty Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AquaBounty Technologies and other key companies, straight to your email.

About AquaBounty Technologies

AquaBounty Technologies (NASDAQ:AQB) is a biotechnology company specializing in the development and commercialization of genetically enhanced aquaculture products. Its flagship offering, the AquaAdvantage Salmon, is an Atlantic salmon variant engineered to grow more rapidly than conventional farmed salmon, reducing the time from hatch to harvest. This innovation is designed to improve production efficiency and help meet global demand for seafood in a more sustainable manner.

Founded in 1991 and headquartered in Waltham, Massachusetts, AquaBounty has navigated a complex regulatory landscape to achieve full approvals for its AquaAdvantage Salmon in Canada, the United States and Panama. The company operates a state-of-the-art aquaculture facility in Indiana for land-based grow-out and maintains broodstock operations in Canada and Panama. These sites enable close oversight of the production cycle and stringent biosecurity measures, while complying with local and international food safety standards.

Beyond salmon, AquaBounty continues to explore advanced breeding techniques and biotechnologies aimed at other high-value aquaculture species. The company leverages proprietary genetic constructs and collaborates with academic institutions and industry partners to enhance growth rates, feed conversion efficiency and environmental footprint across its pipeline.

Under the leadership of President and Chief Executive Officer Ronald P. Stotish, AquaBounty’s management team combines expertise in molecular biology, aquaculture engineering and regulatory affairs. Their collective vision is to position the company at the forefront of sustainable seafood production by delivering innovative solutions that balance economic viability with ecological stewardship.

View AquaBounty Technologies Profile

More Earnings Resources from MarketBeat